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Abstract
Background: Recent community-based research has linked aortic stiffness to the development of atrial fibrillation.
We posit that aortic stiffness contributes to adverse atrial remodeling leading to the persistence of atrial fibrillation
following catheter ablation in lone atrial fibrillation patients, despite the absence of apparent structural heart disease.
Here, we aim to evaluate aortic stiffness in lone atrial fibrillation patients and determine its association with
arrhythmia recurrence following radio-frequency catheter ablation.
Methods: We studied 68 consecutive lone atrial fibrillation patients who underwent catheter ablation procedure for
atrial fibrillation and 50 healthy age- and sex-matched community controls. We performed radial artery applanation
tonometry to obtain central measures of aortic stiffness: pulse pressure, augmentation pressure and augmentation
index. Following ablation, arrhythmia recurrence was monitored at months 3, 6, 9, 12 and 6 monthly thereafter.
Results: Compared to healthy controls, lone atrial fibrillation patients had significantly elevated peripheral pulse
pressure, central pulse pressure, augmentation pressure and larger left atrial dimensions (all P<0.05). During a mean
follow-up of 2.9±1.4 years, 38 of the 68 lone atrial fibrillation patients had atrial fibrillation recurrence after initial
catheter ablation procedure. Neither blood pressure nor aortic stiffness indices differed between patients with and
without atrial fibrillation recurrence. However, patients with highest levels (≥75th percentile) of peripheral pulse
pressure, central pulse pressure and augmentation pressure had higher atrial fibrillation recurrence rates (all
P<0.05). Only central aortic stiffness indices were associated with lower survival free from atrial fibrillation using
Kaplan-Meier analysis.
Conclusion: Aortic stiffness is an important risk factor in patients with lone atrial fibrillation and contributes to higher
atrial fibrillation recurrence following catheter ablation procedure.
Citation: Lau DH, Middeldorp ME, Brooks AG, Ganesan AN, Roberts-Thomson KC, et al. (2013) Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk
Factor for Arrhythmia Recurrence. PLoS ONE 8(10): e76776. doi:10.1371/journal.pone.0076776
Editor: John Calvert, Emory University, United States of America
Received July 3, 2013; Accepted September 2, 2013; Published October 3, 2013
Copyright: © 2013 Lau et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Drs. Lau and Leong are supported by a Postdoctoral Fellowship from the National Health and Medical Research Council of Australia (NHMRC).
Drs. Brooks, Roberts-Thomson and Sanders are supported by the Heart Foundation of Australia (HFA). Dr. Ganesan is supported by a CVL grant from
Pfizer Australia. Dr. Abed is supported by an Australian Postgraduate Award and an Earl Bakken Fellowship from the University of Adelaide. Dr. Lim is
supported by a Postgraduate Scholarship from NHMRC. Dr. Wong is supported by the Rhodes scholarship. Dr. Willoughby is supported by the NHMRC.
This work is supported by an equipment grant from Tom Simpson Trust Fund, HFA. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing interests: The authors have the following interests. Drs. Kalman, Roberts-Thomson and Young report having served on the advisory board of
and having received lecture fees from Medtronic and St Jude Medical. Dr Sanders reports having served on the advisory board of and having received
lecture fees and research funding from Bard Electrophysiology, Biosense-Webster, Medtronic, Merck Sharp & Dohme, Sanofi-Aventis and St. Jude




Atrial fibrillation (AF) has been recognized as an emerging
epidemic. Increased focus on its prevention is thereby
warranted given the limitations with current therapeutic options
[1]. Recently, aortic stiffness has been proposed as a novel
modifiable risk marker for AF, with increased brachial pulse
pressure found to be associated with AF development in the
Framingham community-based observational cohort [2].
Importantly, this association was stronger than systolic blood
PLOS ONE | www.plosone.org 1 October 2013 | Volume 8 | Issue 10 | e76776
pressure alone and remained significant even after adjustment
for established predictive factors such as left atrial enlargement
and left ventricular hypertrophy [2].
However, peripheral derived blood pressures are known to
overestimate true central hemodynamic indices [3]. In
particular, central pressures are important measures of
subclinical organ damage with greater patho-physiological
relevance than peripheral pressures and therefore, better at
predicting disease progression and outcomes, including
coronary restenosis and cardiovascular mortality [3-5]. Central
pulse wave analysis is a clinically validated, non-invasive and
reproducible method for assessment of aortic stiffness [5-7].
Radial artery waveform obtained by applanation tonometry can
be used to derive the following surrogate measures of aortic
stiffness: central systolic blood pressure, central pulse
pressure, augmentation pressure and augmentation index. In
individuals with aortic stiffness, increased pulse wave velocity
results in merging of the incident and reflected arterial waves
leading to increased augmentation pressure as well as central
systolic and pulse pressures.
In this study, we aim to further investigate the role of aortic
stiffness in AF by analyzing the central pulse wave of lone AF
patients who have no apparent structural heart disease or
conditions that predispose them to the arrhythmia. Recently, it
has been demonstrated that lone AF patients have an
abnormal atrial electrical and structural substrate [8-10]. We
posit that aortic stiffness contributes to adverse atrial
remodeling that result in the development and persistence of
lone AF. The impact of such a consequence was studied by
examining arrhythmia recurrence following catheter ablation in
patients with lone AF.
Methods
Study Population
The Research Ethics Committee of the Royal Adelaide
Hospital, Australia approved this study. From a total of 115
consecutive lone AF patients who underwent initial catheter
ablation procedure at our institution for symptomatic AF
between August 2005 and September 2010, 72 agreed to
participate in this study. Due to the presence of AF during
applanation tonometry in 4 patients, we only included data from
the remaining 68 patients for analysis. Lone AF was defined as
previously described by: absence of structural heart disease or
stroke based on history, physical examination, chest X-ray,
routine blood chemistry, and echocardiography; coronary artery
disease was excluded by clinical, ECG or stress test criteria;
pulmonary disease, hypertension, hyperthyroidism and
diabetes were eliminated by appropriate tests [11]. An
additional 50 age- and sex-matched control subjects with no
echocardiographic evidence of structural heart disease or risk
factors for AF were also recruited from the local community. All
patients and control subjects gave informed written consent to
the study protocol.
Blood Pressure and Radial Artery Pulse Wave
Measurements
Measurements of blood pressure and radial artery
applanation tonometry were performed in a quiet, temperature
controlled room (22°C) with subjects in a recumbent position
after 10 minutes of rest. All subjects were instructed to refrain
from alcohol and caffeine consumption for 1 day prior to these
measurements. Brachial blood pressure was the average of the
last 2 readings (out of 3) measured in each subject at 5-
minutes interval using a mercury sphygmomanometer and
appropriately sized arm cuff.
Radial artery pressure waveform was acquired using a high
fidelity applanation tonometer on the same arm (SphygmoCor
Version 9, Atcor Medical, Itasca, IL, USA). The system has
real-time monitoring of waveform quality (Figure 1A) allowing
automatic capture once 11 seconds of acceptable data is
obtained. The algorithm monitored each recording for pulse
height, diastolic and shape variation. Quality of acquired data
was also verified manually to ensure inclusion of only high
quality recordings with operator index of >90%. Aortic pressure
waveform was then derived using a validated generalized
transfer equation [12]. Three measurements were performed
on each subject to provide a mean value for each parameter:
Central and peripheral pulse pressure – taken as the difference
between their respective systolic and diastolic readings;
Augmentation pressure – a measure of reflected pressure
wave, taken as the difference between maximum central
systolic pressure and the pressure at first peak (Figure 1B);
and Augmentation index – taken as the percentage of
augmentation pressure to pulse pressure (AP/PP x 100).
Definitions and Echocardiographic Measurements
Classification of AF was in accordance with expert
consensus statement [13]. Paroxysmal AF was defined as
recurrent AF that terminates spontaneously within 7 days.
Persistent AF was defined as sustained AF lasting more than 7
days or between 2 and 7 days but requiring cardioversion. All
echocardiographic measures were performed according to the
American Society of Echocardiography guidelines [14]. In brief,
left atrial measurements were taken using M-mode in the
standard parasternal long axis view; and in 2-D apical 2- and 4-
chamber views for measurements of left atrial area. Left atrial
volume was calculated using the bi-plane area-length method
and indexed for body surface area to derive left atrial volume
index. Inter-ventricular septum was measured using both M-
mode and 2-D from the parasternal long axis window. Left
ventricular ejection fraction was calculated using the modified
Simpson’s rule.
Electrophysiology Study and Ablation
Electrophysiological procedures were performed with
patients in the fasting state and under conscious sedation
using midazolam and fentanyl. The ablation technique utilized
at our institution has been previously described [8]. In brief, a
single trans-septal puncture was performed under fluoroscopic
guidance for left atrial access (BRK-1 needle, St Jude Medical,
St Paul, MN, USA). The following catheters were used:
Decapolar in the coronary sinus (Live wire Steerable, St Jude
Lau et al. Aortic Stiffness in Lone AF
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Medical); Circular for pulmonary vein mapping (Lasso Variable,
Biosense-Webster, Diamond Bar, CA, USA); and 3.5 mm tip
externally irrigated for ablation (Navistar or Celsius
Thermocool, Biosense-Webster). Electroanatomic mapping
system (CARTO, Biosense-Webster or Ensite NavX, St. Jude
Medical) was used routinely for non-fluoroscopic navigation.
Unfractionated heparin was administered in repeated boluses
to maintain an activated clotting time of 300-350 seconds.
The ablation strategy included wide-encircling pulmonary
vein ablation with an endpoint of pulmonary vein isolation in all
patients. Further substrate modification was performed for
patients with AF episodes lasting longer than 48 hours. This
included linear ablation at the left atrial roof with endpoint of
conduction block and/or electrogram-guided ablation at highly
fractionated sites with abolition of fractionated signals as
endpoint. Typically, radiofrequency power of 30W was used for
pulmonary vein ablation and up to 35W for substrate
modification while irrigation rate was fixed at 30 ml/min.
Follow-Up
Patients were reviewed 3 monthly for the first year after
ablation and 6 monthly thereafter. At each review, AF
recurrence was ascertained from ambulatory 7-day Holter
monitoring, 12-lead ECG and patients’ symptoms. All patients
were treated with flecainide or sotalol for the first 6 weeks
following the ablation procedure. Ongoing anti-arrhythmic drug
use was at the discretion of the treating physician. Warfarin
anti-coagulation was routine in all patients for a period of 3
Figure 1.  Peripheral and Central Pulse Waveforms.  (A) This figure depicts a peripheral waveform obtained via radial artery
tonometry. In this sample from a lone AF patient, peripheral blood pressure is 129/81 with a pulse pressure of 48 mmHg. (B) Aortic
waveform can then be derived from peripheral waveform shown in (A) with the SphygmoCor software’s generalized transfer
function. The central blood pressure is 122/82 with a pulse pressure of 40 mmHg. Augmentation pressure is a measure of reflected
pressure wave, which is the difference between aortic systolic pressure and the first peak of the waveform. Augmentation index in
this example is 12/40 X 100 = 30%.
doi: 10.1371/journal.pone.0076776.g001
Lau et al. Aortic Stiffness in Lone AF
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e76776
months following ablation and continued in those with a
CHADS2 score ≥2. Procedural success was determined as the
absence of any atrial arrhythmia longer than 30 seconds
without anti-arrhythmic drug use after a blanking period of 6
weeks.
Statistical Analysis
Continuous variables were expressed as means ±SD or
median with inter-quartile range accordingly using the Shapiro-
Wilks test of normality. Data were compared using the unpaired
Student’s t-test or Wilcoxon rank-sum test as appropriate.
Categorical data were expressed as numbers and
percentages, and compared using Fisher’s exact test. Kaplan-
Meier survival analysis with log-rank testing was applied to
compare post ablation AF recurrence. Statistical significance
was established with two-tailed P value less than 0.05.
Results
Baseline Characteristics
Patient characteristics are presented in Table 1. Of the 68
lone AF patients, 43 had paroxysmal AF and 25 had persistent
AF. Body mass index was similar between the two groups.
Lone AF patients had significantly larger left atrial dimensions
even though these were still within reference range for normal
adults.
Peripheral and Central Pressures
The various peripheral and central blood pressure
parameters are detailed in Table 2. Specifically, there was no
significant difference in either peripheral or central systolic,
diastolic & mean blood pressures. However, lone AF patients
had significantly elevated measures of aortic stiffness:
peripheral pulse pressure, central pulse pressure and
augmentation pressure. Examples of peripheral and central
pulse waveforms of the two groups are shown in Figure 2.
Table 1. Baseline Characteristics.
 Control (n=50) Lone AF (n=68) P
Age (yr) 58.6±11.3 59.3±10.5 0.6
Male sex (%) 74.0 73.5 1.0
Body mass index (kg/m2) 26.9±4.4 27.5±4.5 0.5
Duration of AF (months) - 60 (IQR 43-120) -
Longest AF episodes (days) - 2 (IQR 0.5-30) -
Echocardiography    
Left atrial parasternal size (cm) 3.4±0.5 3.9±0.7 0.004
Left atrial volume (ml) 52.7±15.5 66.0±23.1 0.002
Left atrial volume index (ml/m2) 26.8±6.8 32.3±10.8 0.005
Left atrial area (cm2) 18.5±3.5 21.6±5.0 <0.001
Inter-ventricular septum (mm) 9.8±1.5 10.1±1.5 0.4
Left ventricular ejection fraction (%) 64±5 64±7 0.7
IQR: Inter-quartile range.
doi: 10.1371/journal.pone.0076776.t001
Aortic Stiffness and Atrial Fibrillation Recurrence
During a mean (±SD) follow-up of 2.9±1.4 years, 38 of the 68
lone AF patients had recurrence of AF at 31±27 weeks after
single ablation procedure. As shown in Table 3, there was no
significant difference in patient characteristics, AF type and
echocardiographic parameters between cases and controls.
Specifically, there was no difference in anti-hypertensive
medication use including beta-blockers, renin-angiotensin
system inhibitors, calcium channel blockers and diuretic
agents.
Even though no differences were seen in both mean
peripheral and central pressures, patients with highest levels of
aortic stiffness (≥75th percentile) had higher AF recurrence
rates when compared to those with values less than the 75th
percentile (Peripheral pulse pressure ≥57mmHg: 82% vs. 47%,
P=0.01; Central pulse pressure ≥45mmHg: 87% vs. 47%,
P=0.008; Augmentation pressure ≥12mmHg: 76% vs. 48%,
P=0.04; Augmentation index ≥33%: 76% vs. 49%, P=0.055).
Importantly, corresponding analysis of those with highest levels
of central or peripheral systolic, diastolic and mean blood
pressure (≥75th percentile) showed no relationship to higher AF
recurrence rates. Likewise, left atrial dimensions (parasternal
area & volume ≥75th percentile) and inter-ventricular septal
thickness (≥75th percentile) were not significantly associated
with higher AF recurrence (all P>0.7). In addition, only central
aortic stiffness indices were associated with lower survival free
from AF using Kaplan-Meier statistics (Central pulse pressure
≥75th percentile, P=0.02 – Figure 3A; Augmentation pressure
≥75th percentile, P=0.04 – Figure 3B; Augmentation index ≥75th
percentile, P=0.053 & Peripheral pulse pressure ≥75th
percentile, P=0.06 – both not illustrated).
Discussion
Major Findings
This study utilized well-validated, non-invasive central pulse
wave analysis technique to examine central pressures and
aortic stiffness in patients with lone AF who had no apparent
Table 2. Peripheral and Central Blood Pressures.
 Control (n=50) Lone AF (n=68) P
Peripheral Pressures (mmHg)    
Systolic 125±8 129±14 0.06
Diastolic 80±7 79±10 0.7
Mean 95±6 95±10 0.9
Pulse Pressure 45±8 50±12 0.009
Central Pressures (mmHg)    
Systolic 114±8 117±14 0.08
Diastolic 81±7 79±10 0.4
Mean 95±7 95±11 0.7
Pulse Pressure 33±6 38±11 0.02
Augmentation Pressure 6±3 9±7 0.04
Augmentation index (%) 21±10 22±13 0.5
doi: 10.1371/journal.pone.0076776.t002
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structural heart disease and risk factors for AF. The major
findings are as follows:
1 Increased aortic stiffness (higher pulse pressure and
augmentation pressure) was evident in lone AF patients as
compared to controls;
2 Measures of aortic stiffness demonstrated stronger
association with AF recurrence following catheter ablation than
standard brachial blood pressure measures and conventional
echocardiographic parameters;
3 Lone AF patients had larger left atrial dimensions than
controls.
Therefore, this study implicates aortic stiffness as a silent
contributing factor in the development of lone AF. Elevated
aortic stiffness, by leading to abnormal atrial remodeling,
creates a path to development of the substrate that develops
apparently “lone” AF.
Aortic Stiffness: A Silent Factor Leading to Remodeling
and Atrial Fibrillation
Studies in lone AF patients have alluded to several
underlying atrial abnormalities thereby pointing to the possibility
of as yet unrecognized risk factors. These abnormalities
include: increased inflammation, diastolic dysfunction,
increased fibrosis and microvascular dysfunction [15-18]. More
recently, our group has demonstrated further evidence of
significant electrical and structural changes in lone AF atria
[8,9]. This included structural abnormalities evidenced by loss
of myocardial voltage, conduction slowing, sinus node
dysfunction and prolonged atrial refractoriness. Non-invasive
delayed enhancement magnetic resonance imaging has also
demonstrated this abnormal atrial substrate [10]. As such, lone
AF patients are ideal candidates for studies aiming to uncover
novel AF risk factors in the absence of structural heart disease
[4,5]. As seen in this study, both peripheral and central
measures of aortic stiffness were higher in lone AF patients
and associated with higher arrhythmia recurrence following
catheter ablation. Aortic stiffness may signify an ‘atrial-
myopathy’ in patients who have apparent normal left atrial
dimensions, ventricular thickness and brachial systolic blood
pressure. The present study also affirms the findings of the
Framingham study linking aortic stiffness to the development of
AF [2]. We believe aortic stiffness is an unrecognized silent
Figure 2.  Examples of Peripheral and Central Pulse Waveforms.  (A) Waveforms from a control subject showing peripheral
pressures (black) of 128/76 with a pulse pressure of 52 mmHg and central pressures of 115/77 (blue) with a pulse pressure of 38
mmHg. Central augmentation pressure (red, dotted) is 7 mmHg. (B) Waveforms from a patient with lone AF showing peripheral
pressures (black) of 120/54 with a pulse pressure of 66 mmHg and central pressures of 106/54 (blue) with a pulse pressure of 52
mmHg. Central augmentation pressure (red, dotted) is 12 mmHg.
doi: 10.1371/journal.pone.0076776.g002
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factor in lone AF contributing to occult abnormal atrial
remodeling.
Causes of Aortic Stiffness: Implications in Atrial
Fibrillation
The causes of aortic stiffness remain incompletely
understood. The lack of association between aortic stiffness
and conventional cardiac risk factors other than hypertension
and aging has been well documented [19-21]. Other possible
contributing factors include inflammation and mechanical stress
[20,22,23]. Interestingly, recent reports had also found
increased arterial stiffness and P-wave duration in subjects
with pre-hypertension [24,25]. Indeed, systolic blood pressure
in the pre-hypertensive range has been shown to be
independently associated with incident AF in a large
prospective study [26]. Furthermore, pre-clinical work has
shown a relationship between short-term hypertension and
increased atrial inflammation leading to a substrate for AF [27].
The atrial remodeling process in the same hypertensive model
was progressive, highlighting the potential benefits of early
treatment to prevent formation of an arrhythmogenic substrate
[28]. Taken together, aortic stiffness may identify a subset of
at-risk patients in the pre-hypertensive spectrum. Recognition







Age (yr) 59.1±11.9 59.6±9.4 0.8
Male sex (%) 76.7 71.1 0.8
Body Mass Index (kg/m2) 27.2±4.2 27.7±4.8 0.7
Paroxysmal/Persistent AF (%) 63.3/36.7 63.2/36.8 1.0
Echocardiography    
Left atrial parasternal size (cm) 3.8±0.5 3.9±0.8 0.7
Left atrial volume (ml) 62.5±17.5 68.9±27.0 0.4
Left atrial volume index (ml/m2) 30.3±8.5 34.2±12.4 0.2
Left atrial area (cm2) 20.8±4.1 22.3±5.6 0.3
Inter-ventricular septum (mm) 10.1±1.9 10.9±1.7 0.09
Left ventricular ejection fraction (%) 65.2±7.4 63.5±7.0 0.3
Peripheral Pressures (mmHg)    
Systolic 127±14 130±14 0.3
Diastolic 80±10 78±10 0.8
Mean 95±10 95±10 1.0
Pulse Pressure 47±9 52±14 0.3
Central Pressures (mmHg)    
Systolic 116±13 119±14 0.4
Diastolic 81±10 78±10 0.4
Mean 95±11 95±11 1.0
Pulse Pressure 35±8 40±13 0.3
Augmentation Pressure 7±4 10±8 0.2
Augmentation index (%) 21±10 23±14 0.6
doi: 10.1371/journal.pone.0076776.t003
and targeting of aortic stiffness in patients with or at risk of AF
may be important in our bid to reduce the burden of this
emerging epidemic.
Aortic Stiffness: Central versus Peripheral Measures
Theoretically, central pressure is more patho-physiologically
relevant to the heart than their peripheral counterparts as its
proximity will exert greater strain leading to increased afterload
and impaired relaxation [5]. A recent systematic review and
meta-analysis highlighted the value of central hemodynamic
indices in predicting cardiovascular outcomes [3]. Central pulse
wave analysis from applanation tonometry of the radial artery
has been accepted as a valid measure of subclinical target
organ damage. Central estimates of aortic stiffness as used in
this study provided additional information that may also be
useful for monitoring of therapeutic effects. Recently, the CAFÉ
investigators have shown that different anti-hypertensive
agents can have significantly different effects on central aortic
pressures despite similar brachial readings [29]. Specifically,
amlodipine±perindopril combination had greater effects on
central pressures than atenolol±thiazide. While heart rate
reduction with beta-blockade is thought to be responsible for
the less effective central pressure reduction, whether the
difference in central aortic pressures could explain the different
clinical outcomes in these 2 groups remains unknown [30].
Nevertheless, further evaluation is required to assess central
aortic stiffness in AF.
Clinical Implications
This study affirms aortic stiffness as a novel modifiable risk
factor for AF. It can be used to identify “high-risk” pre-
hypertensive patients with subclinical atrio-myopathy. Further
studies are necessary to determine whether targeting of aortic
stiffness with anti-hypertensive medications may modify the
burden or progression of AF. Of note, agents with central blood
pressure effects such as inhibitors of the renin angiotensin
system have also been shown to reduce the occurrence of AF
in various patient groups including normotensive lone AF
patients [31,32].
Study Limitations
We did not have longitudinal measures of central pulse wave
analysis. Inclusion of pulse wave velocity measurements would
have strengthened our findings. Pulse wave analysis ideally
requires stable artery waveforms, which is difficult when a
subject is in AF.
Conclusions
Lone AF is associated with greater aortic stiffness; which
contributes to higher AF recurrence following catheter ablation
procedures. Active monitoring and targeting of this novel risk
factor may improve outcomes in patients with AF.
Lau et al. Aortic Stiffness in Lone AF
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Figure 3.  Kaplan-Meier Survival Curves.  (A) Lone AF patients with central pulse pressure ≥75th percentile had lower survival free
from AF following catheter ablation. (B) Similarly, lone AF patients with augmentation pressure ≥75th percentile had poorer outcome
following catheter ablation.
doi: 10.1371/journal.pone.0076776.g003
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